McDermott, Will & Emery advised the investors, while Osborne Clarke advised King’s College in London. Heqet Therapeutics, a Turin-based start-up (a biotech spin-out from King’s College...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here